YOKNEAM, ISRAEL--(Marketwire - October 20, 2008) - Syneron™ Medical Ltd. (NASDAQ: ELOS) announced today that the Company expects to report third quarter 2008 revenue between $29 - $30 million, compared to $33 million in the third quarter of 2007. Revenue for the first three quarters of 2008 is expected to be in a range of $101 - $102 million, compared to $102.9 million in the first nine months of 2007. Syneron maintained good profitability with gross margins of 76% - 77% and net profit of $3.4 - $3.7 million for the third quarter of 2008. Syneron expects to report GAAP earnings per share of $0.11 - $0.13 for the third quarter.
